0.9221USD-8.70%Mkt Cap: 5.64M USDP/E: —Last update: 2026-05-26
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at-home administration without medical profes…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap5.64M USD
Enterprise Value4.64M USD
Revenue (TTM)2.18M USD
Gross Profit153.00K USD
Net Income (TTM)-18.18M USD
Revenue/Share1.520 USD
Last Price0.9221 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.37
EV/Revenue2.13
P/S1.58
P/B0.11
EPS (TTM)-3.67
EPS (Forward)—
52W Range
0.84000% of range17.40
52W High17.40 USD
52W Low0.8400 USD
Profitability
Gross Margin5.99%
Oper. Margin-568.30%
EBITDA Margin0.00%
Profit Margin-712.30%
ROE-54.29%
ROA-44.22%
Growth
Revenue Growth-36.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.37M USD
CapEx (TTM)60.00K USD
FCF Margin-311.15%
FCF Yield-120.35%
Net Debt-1.02M USD
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity0.04
Current Ratio0.90
Quick Ratio0.37
Book Value/Sh8.651 USD
Cash/Share0.3670 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateAug 12, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.70M
Float4.76M
Insiders5.42%
Institutions1.04%
Short Interest
Short Ratio0.0d
Short % Float0.30%
Short % Out.0.30%
Shares Short10.98K
Short (prev mo.)470.31K
Technical
SMA 501.529 (-39.7%)
SMA 2003.667 (-74.9%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)566.64K
Avg Vol (10d)1.01M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—